Content deleted Content added
mNo edit summary |
Added a paragraph about the complications of diabetes and what kinds of management strategies there are such as controlling other risk factors. |
||
Line 5:
== Overview ==
Diabetes is a chronic disease and it is important to have control of the diabetes as it can cause many complications. Diabetes affects the blood vessels in the body, such as capillaries and arteries, which are the routes blood take to deliver nutrients and oxygen to the organs in the body.<ref name=":4">{{Cite journal |last=Kushner |first=Pamela R. |last2=Cavender |first2=Matthew A. |last3=Mende |first3=Christian W. |date=2022-10-14 |title=Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases |url=https://diabetesjournals.org/clinical/article/40/4/401/144956/Role-of-Primary-Care-Clinicians-in-the-Management |journal=Clinical Diabetes |language=en |volume=40 |issue=4 |pages=401–412 |doi=10.2337/cd21-0119 |issn=0891-8929 |pmc=PMC9606551 |pmid=36381309}}</ref> By affecting the blood flow, diabetes increases the risk of other conditions such as strokes and heart disease (heart attacks).<ref name=":5" /> Diabetes also affects small blood vessels, such as capillaries, in organs such as the eyes and the kidneys to cause diabetic retinopathy and diabetic nephropathy, respectively.<ref name=":4" /> Therefore, it becomes important to lower the sugar levels in the body in addition to control other risk factors that also contribute to the major complications such as smoking, alcohol use, weight, blood pressure, and cholesterol.<ref name=":3" /> Often, the recommended treatment is a combination of lifestyle changes such as increasing exercise and healthy eating, along with medications to help control the blood glucose levels in the long term.<ref name=":5" />
The treatment goals are related to effective control of [[blood glucose]], [[blood pressure]] and [[lipid]]s, to reduce the risk of long-term effects associated with diabetes. They are suggested in [[clinical practice guideline]]s released by various national and international diabetes organizations.<ref name="American Diabetes Association x899">{{cite web | title=Practice Guidelines Resources | website=American Diabetes Association | url=https://professional.diabetes.org/content-page/practice-guidelines-resources | access-date=2023-07-12}}</ref><ref name="Hur Moon Park Kim 2021 pp. 461–481">{{cite journal | last1=Hur | first1=Kyu Yeon | last2=Moon | first2=Min Kyong | last3=Park | first3=Jong Suk | last4=Kim | first4=Soo-Kyung | last5=Lee | first5=Seung-Hwan | last6=Yun | first6=Jae-Seung | last7=Baek | first7=Jong Ha | last8=Noh | first8=Junghyun | last9=Lee | first9=Byung-Wan | last10=Oh | first10=Tae Jung | last11=Chon | first11=Suk | last12=Yang | first12=Ye Seul | last13=Son | first13=Jang Won | last14=Choi | first14=Jong Han | last15=Song | first15=Kee Ho | last16=Kim | first16=Nam Hoon | last17=Kim | first17=Sang Yong | last18=Kim | first18=Jin Wha | last19=Rhee | first19=Sang Youl | last20=Lee | first20=You-Bin | title=2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association | journal=Diabetes & Metabolism Journal | publisher=Korean Diabetes Association | volume=45 | issue=4 | date=2021-07-31 | issn=2233-6079 | doi=10.4093/dmj.2021.0156 | pages=461–481| pmid=34352984 | pmc=8369224 | doi-access=free }}</ref>▼
'''Goals'''
▲
The targets are:
| |||